Form C Apelab, Inc.
- Indexes close up more than 1% as investors assess Fed news
- Nike (NKE) Stock Falls On a Revenue Miss and Slashed FY Sales Outlook, Analysts Bullish Despite NT Supply Chain Challenges
- China Tells Local Authorities to Prepare For a 'Possible Storm' and Prevent Unrest as Evergrande Crisis Unravels - WSJ
- Salesforce (CRM) Raises FY22 Revenue Guidance; Initiates FY23 Revenue
- Oil prices rise, hit 2-month highs on supply worries
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
C 0001873984 XXXXXXXX LIVE false false false Apelab, Inc. Corporation DE 07-02-2015 5200 W Century Blvd. Los Angeles CA 90045 https://www.zoe.com/ N StartEngine Capital, LLC 0001665160 007-00007 7.0 percent Two percent (2%) of securities of the total amount of investments raised in the offering, along the same terms as investors. Common Stock 142857 0.07000 N/A 9999.99 Y Other At issuer's discretion, with priority given to StartEngine Owners 1069998.86 01-26-2022 10 107518.00 86246.00 77260.00 82122.00 29810.00 3459.00 65881.00 89050.00 676562.00 460100.00 97489.00 130404.00 46009.00 0.00 0.00 0.00 -169188.00 -29612.00 AL AK AZ AR CA CO CT DC DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Apelab, Inc. Emilie Joly President, CEO, Principal Executive Officer, Director, Principal Financial Officer and Principal Accounting Officer Emilie Joly President, CEO, Principal Executive Officer, Director, Principal Financial Officer and Principal Accounting Officer 07-29-2021
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Half-year report
- Jyske Bank A/S, Transactions by persons discharging managerial responsibilities and persons closely associated with them
- Bavarian Nordic’s COVID-19 Funding Agreement with the Danish Ministry of Health Receives Final Approval from Parliament
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!